SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-106433
Filing Date
2023-04-19
Accepted
2023-04-19 16:02:53
Documents
12
Period of Report
2023-04-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d488839d8k.htm   iXBRL 8-K 23159
  Complete submission text file 0001193125-23-106433.txt   148300

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA iron-20230418.xsd EX-101.SCH 2866
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE iron-20230418_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE iron-20230418_pre.xml EX-101.PRE 11718
6 EXTRACTED XBRL INSTANCE DOCUMENT d488839d8k_htm.xml XML 3466
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Disc Medicine, Inc. (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39438 | Film No.: 23830055
SIC: 2834 Pharmaceutical Preparations